The Economic Impact of Treating Deep Vein Thrombosis with Low-Molecular-Weight Heparin: Outcome of Therapy and Health Economy Aspects

Publisher： Karger

E-ISSN： 1424-8840|28|3|8-16

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.28, Iss.3, 2004-11, pp. : 8-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Can All Patients with Deep Vein Thrombosis Receive Low-Molecular-Weight Heparin in an Outpatient Setting?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 29, Iss. 1, 2004-11 ,pp. : 84-88

Karger

Access to resources Recommend Favorite

Outpatient Therapy with Low-Molecular-Weight Heparins: New Perspectives for Treatment of Deep Vein Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 91-94

Karger

Access to resources Recommend Favorite

Early versus Delayed Introduction of Oral Vitamin K Antagonists in Combination with Low-Molecular-Weight Heparin in the Treatment of Deep Vein Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 2, 1999-03 ,pp. : 70-77

Karger

Access to resources Recommend Favorite

Antithrombotic Therapy in Coronary Ischaemia: The Expanding Role of Low-Molecular-Weight Heparin

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3, 2004-11 ,pp. : 35-42

Karger

Access to resources Recommend Favorite

Combinations of Low Doses of Unfractionated Heparin and of Low-Molecular-Weight Heparin Prevent Experimental Venous Thrombosis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 34, Iss. 6, 2006-06 ,pp. : 263-268

Karger

Access to resources Recommend Favorite